BioSpace News Archive

SXC-2023 has demonstrated a compelling profile across a range of non-clinical studies.

The event will bring together leading expert allergists to discuss the emerging treatment landscape in peanut allergy.

The two new execs bring global operations and commercialization expertise to the company.

The platform offers direct access to molecules for independent research as well as other molecules for partnering with Boehringer Ingelheim.

The new pacemakers also allow patients to have MRI scans in either 1.5 or 3 Tesla machines.

Glactone Pharma receives new funding from Vinnova In strong competition and after external examination, Glactone Pharma has been awarded a SEK 886,500 grant from Vinnova in the second phase of a program aimed at innovative startup companies.

Juan Fueyo, MD, Professor in the Department of Neuro-Oncology at MD Anderson Cancer Center, gave an oral presentation of clinical results showing that DNX-2401 therapy for high grade malignant glioma leads to a reduction in the expression of TIM3, a key marker of T-cell exhaustion and negative regulator of antitumor immunity.

As stated in the 10-Q, Jaguar registered net income and comprehensive income of approximately $4.75 million in third quarter of 2017.

Agendia announces that the AJCC has recently issued a Breast Cancer Update and Correction which revised and clarified the Cancer Staging Manual, 8th Edition regarding the use of multigene genomic profiles for Pathological Prognostic Staging.

Eli Lilly will announce its financial guidance for 2018 on Wednesday, December 13, 2017.